In this study, we investigate the effect of ASPP2 deficiency on NAFLD, lipid metabolism and gut microbiota using ASPP2 globally heterozygous knockout (ASPP2+/-) mice. This evidence concerns the gene TP53BP2 and metabolic dysfunction-associated steatotic liver disease.